Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)
Optimization of the Flare Management in Rheumatoid Arthritis (RA) by Implementing Patient-driven Systematic Changes to the RA Ambulatory Care Stream
Status: Enrolling
Updated:  3/20/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)
Optimization of the Flare Management in Rheumatoid Arthritis (RA) by Implementing Patient-driven Systematic Changes to the RA Ambulatory Care Stream
Status: Enrolling
Updated: 3/20/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
A Single-Center, Epidemiological Study of the Survivorship of the DePuy Sigma HP Unicompartmental Knee Prosthesis
Two and Five-Year Survivorship of Unicompartmental Knee Arthroplasty Using DePuy Sigma HP Replacement
Status: Enrolling
Updated:  3/20/2018
Mississippi sports Medicine and Orthopaedic Center
mi
from
Jackson, MS
A Single-Center, Epidemiological Study of the Survivorship of the DePuy Sigma HP Unicompartmental Knee Prosthesis
Two and Five-Year Survivorship of Unicompartmental Knee Arthroplasty Using DePuy Sigma HP Replacement
Status: Enrolling
Updated: 3/20/2018
Mississippi sports Medicine and Orthopaedic Center
mi
from
Jackson, MS
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Little Rock, AR
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Los Angeles, CA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Ventura, CA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Ventura, CA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Whittier, CA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Whittier, CA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Hamden, CT
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Hamden, CT
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Boca Raton, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Boynton Beach, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Brandon, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Brandon, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Doral, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Doral, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Hialeah, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Jacksonville, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Miami Lakes, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Miami, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Pembroke Pines, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Pinellas Park, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Sarasota, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
West Palm Beach, FL
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Decatur, GA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Decatur, GA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Meridian, ID
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Meridian, ID
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Lexington, KY
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Louisville, KY
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Worcester, MA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Ann Arbor, MI
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Grand Rapids, MI
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Lansing, MI
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Lansing, MI
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Tupelo, MS
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Tupelo, MS
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Las Vegas, NV
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Freehold, NJ
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Freehold, NJ
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Durham, NC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Greenville, NC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Greenville, NC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Salisbury, NC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Wilmington, NC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Cincinnati, OH
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Columbus, OH
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Middleburg Heights, OH
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Oklahoma City, OK
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Duncansville, PA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Media, PA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Media, PA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Wyomissing, PA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Charleston, SC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Fort Mill, SC
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Fort Mill, SC
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Jackson, TN
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Jackson, TN
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Memphis, TN
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Memphis, TN
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Amarillo, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Amarillo, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Baytown, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Baytown, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Beaumont, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Beaumont, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Corpus Christi, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
Nichi-Iko Investigational Site
mi
from
Cypress, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Cypress, TX
Click here to add this to my saved trials